DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Jagannath S, Barlogie B, Berenson J. et al.
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma.
Br J Haematol 2004; 127: 165-172
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.